Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in <font color="red">patients_2</font> <font color="red">with_2</font> <font color="red">mixed_2</font> <font color="red">dyslipidaemia_2</font> <font color="red">and_2</font> <font color="red">metabolic_2</font> <font color="red">syndrome_2</font> <font color="red">._2</font> 
<br>
<br> BACKGROUND <font color="red">Raised_1</font> <font color="red">triglycerides_1</font> <font color="red">(_1</font> <font color="red">TG_1</font> <font color="red">)_1</font> <font color="red">,_1</font> <font color="red">decreased_1</font> <font color="red">high_1</font> <font color="red">-_1</font> <font color="red">density_1</font> <font color="red">lipoprotein_1</font> <font color="red">cholesterol_1</font> <font color="red">(_1</font> <font color="red">HDL_1</font> <font color="red">-_1</font> <font color="red">C_1</font> <font color="red">)_1</font> <font color="red">levels_1</font> <font color="red">and_1</font> <font color="red">a_1</font> <font color="red">predominance_1</font> <font color="red">of_1</font> <font color="red">small_1</font> <font color="red">dense_1</font> <font color="red">low_1</font> <font color="red">density_1</font> <font color="red">lipoproteins_1</font> <font color="red">(_1</font> <font color="red">sdLDL_1</font> <font color="red">)_1</font> are characteristics of the <font color="red">metabolic_2</font> <font color="red">syndrome_2</font> <font color="red">(_2</font> <font color="red">MetS_2</font> <font color="red">)_2</font> <font color="red">._2</font> 
<br> OBJECTIVE To compare the effect of high - dose rosuvastatin monotherapy with moderate dosing combined with fenofibrate or ω-3 fatty acids on the lipoprotein subfraction profile in <font color="red">patients_2</font> <font color="red">with_2</font> <font color="red">mixed_2</font> <font color="red">dyslipidaemia_2</font> <font color="red">and_2</font> <font color="red">MetS._2</font> 
<br> METHODS We previously randomised <font color="red">patients_2</font> <font color="red">with_2</font> <font color="red">low_2</font> <font color="red">-_2</font> <font color="red">density_2</font> <font color="red">lipoprotein_2</font> <font color="red">cholesterol_2</font> <font color="red">(_2</font> <font color="red">LDL_2</font> <font color="red">-_2</font> <font color="red">C_2</font> <font color="red">)_2</font> <font color="red">>_2</font> <font color="red">160_2</font> <font color="red">and_2</font> <font color="red">TG_2</font> <font color="red">>_2</font> <font color="red">200_2</font> <font color="red"> _2</font> <font color="red">mg_2</font> <font color="red">/_2</font> <font color="red">dl_2</font> to rosuvastatin monotherapy 40   mg / day ( R group , n = 30 ) or rosuvastatin 10 mg / day combined with fenofibrate 200 mg / day ( RF group , n = 30 ) or ω-3 fatty acids 2 g / day ( Rω group , n = 30 ) . In the present study , <font color="red">only_1</font> <font color="red">patients_2</font> <font color="red">with_2</font> <font color="red">MetS_2</font> <font color="red">were_1</font> <font color="red">included_1</font> <font color="red">(_1</font> <font color="red">24_1</font> <font color="red">,_1</font> <font color="red">23_1</font> <font color="red">and_1</font> <font color="red">24_1</font> <font color="red">in_1</font> <font color="red">the_1</font> <font color="red">R_1</font> <font color="red">,_1</font> <font color="red">RF_1</font> <font color="red">and_1</font> <font color="red">Rω_1</font> <font color="red">groups_1</font> <font color="red">respectively_1</font> <font color="red">)_1</font> <font color="red">._1</font> At baseline and after 12 weeks of treatment , the lipoprotein subfraction profile was determined by polyacrylamide 3% gel electrophoresis . 
<br> RESULTS The mean LDL size was significantly increased in all groups . This change was more prominent with RF than with other treatments in parallel with its greater hypotriglyceridemic capacity ( p < 0.05 compared with R and Rω ) . A decrease in insulin resistance by RF was also noted . Only RF significantly raised HDL - C levels ( by 7.7% , p < 0.05 ) by increasing the cholesterol of small HDL particles . The cholesterol of larger HDL subclasses was significantly increased by R and Rω. 
<br> CONCLUSIONS All regimens increased mean LDL size ; RF was the most effective . A differential effect of treatments was noted on the HDL subfraction profile .